BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22370800)

  • 1. [Off-label therapy from the perspective of the medical insurance service].
    Grell L; Rieger M
    Z Rheumatol; 2012 Feb; 71(2):101-4, 106-7. PubMed ID: 22370800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].
    Janzen RW; Ludwig WD;
    Z Rheumatol; 2012 Feb; 71(2):108-10, 112-8. PubMed ID: 22370801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Off-label therapy in rheumatology].
    Krüger K; Sieper J
    Z Rheumatol; 2012 Feb; 71(2):99-100. PubMed ID: 22370799
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leflunomide and TNF inhibitors. Experiences from precription recourse proceedings].
    Brandt-Jürgens J
    Z Rheumatol; 2013 Mar; 72(2):114-6. PubMed ID: 23223912
    [No Abstract]   [Full Text] [Related]  

  • 5. [Off-label therapy of rheumatoid arthritis and spondyloarthritis].
    Krüger K; Sieper J
    Z Rheumatol; 2012 Feb; 71(2):122-4, 126. PubMed ID: 22370803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Off-label use of drugs--the legal framework].
    Koyuncu A
    Dtsch Med Wochenschr; 2012 Jul; 137(30):1519-23. PubMed ID: 22869512
    [No Abstract]   [Full Text] [Related]  

  • 7. Off-label prescriptions and decisions on reimbursement requests in Germany - a retrospective analysis.
    Seidenschnur KEK; Dressler C; Weller K; Nast A; Werner RN
    J Dtsch Dermatol Ges; 2017 Nov; 15(11):1103-1109. PubMed ID: 29064628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Off-label use in oncology: an inexhaustible topic?!].
    Weissbach L; Riese J
    Urologe A; 2006 Nov; 45(11):1410, 1412-4. PubMed ID: 17043888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].
    Harder Yv
    Urologe A; 2007 Oct; 46(10):1429-34. PubMed ID: 17786403
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prescribing fictitiously approved drugs: regress threatens!].
    Walbert H
    MMW Fortschr Med; 2012 Apr; 154(6):10. PubMed ID: 22642016
    [No Abstract]   [Full Text] [Related]  

  • 11. [Public financing for off-label use of drugs].
    Hammerman A; Lipschitz Y; Pliskin J; Greenberg D
    Harefuah; 2011 Feb; 150(2):163-7, 204. PubMed ID: 22164947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IGeL - a questionable debate].
    Schaefer C
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(7):540-1. PubMed ID: 22981030
    [No Abstract]   [Full Text] [Related]  

  • 13. [The importance of biosimilars medicines for private and statutory health insurance].
    Bretthauer B
    Versicherungsmedizin; 2016 Dec; 68(4):173-5. PubMed ID: 29144116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Authorization and reimbursement of orphan drugs in an international comparison].
    Roll K; Stargardt T; Schreyögg J
    Gesundheitswesen; 2011 Aug; 73(8-9):504-14. PubMed ID: 20848380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Appropriate off-label prescription in practice].
    Augustin M
    Hautarzt; 2013 Oct; 64(10):728-35. PubMed ID: 24150820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Legal decisions of german supreme courts about prescription of drugs for not registered indications ("off-label-use")].
    Wetterling T
    Fortschr Neurol Psychiatr; 2004 May; 72(5):255-9. PubMed ID: 15136946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The rheumatologist's conflict between "off-label" prescription and failure to render assistance].
    Hellmich B; Gross WL
    Z Rheumatol; 2003 Feb; 62(1):34-5. PubMed ID: 12624800
    [No Abstract]   [Full Text] [Related]  

  • 18. Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications.
    Paczynski RP; Alexander GC; Chinchilli VM; Kruszewski SP
    Int J Risk Saf Med; 2012 Jan; 24(3):137-46. PubMed ID: 22936056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Off-label prescription of drugs in the statutory health insurance].
    Niederauer HH
    Gesundheitswesen; 2010 Feb; 72(2):116-9. PubMed ID: 19894208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Off-label use in dermatological practice. The conflict between professional duty and legal requirements].
    Brunne V; Mertins G; Reimann G; Brockmeyer NH
    Hautarzt; 2004 Aug; 55(8):727-34. PubMed ID: 15241515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.